neurodegenerative

(redirected from Neurodegenerative disease)
Also found in: Dictionary, Medical, Wikipedia.

neurodegenerative

[‚nu̇·rō·di′jen·rəd·iv]
(pathology)
Characterized by the gradual and progressive loss of nerve cells.
Mentioned in ?
References in periodicals archive ?
Presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting, researchers are not sure why spontaneous and unexplained disturbance in REM sleep should lead to a neurodegenerative disease like Parkinson's, but new longitudinal imaging data show a clear correlation between idiopathic REM behavior disorder and dysfunction of the dopamine transporter system involved in a wide range of vital brain functions, including memory and motor control.
REM sleep disorder a sign of impending neurodegenerative disease
This report and its recommendations are based on the conference "Early Environmental Origins of Neurodegenerative Disease in Later Life: Research and Risk Assessment" sponsored by the Mount Sinai Center for Children's Health and the Environment.
Early environmental origins of neurodegenerative disease in later life
Appel, a renowned and recognized global leader in neuromuscular and neurodegenerative disease research, has been working in concert with Dr.
Power3 and The Methodist Hospital Research Institute form collaborative research agreement for neurodegenerative disease blood test serum proteins
A half dozen or so neurodegenerative diseases stem from an excess of CAG repeats.
Let's repeat: mutation gums up brain cells
Highlights include the perspective by David Schubert and Pamela Maher of the Salk Institute for Biological Studies (CA, USA) that considers a different approach to drug discovery in this disease area, highlighting the fact that there are currently no drugs that halt the progression of any age-associated neurodegenerative disease.
Research and Markets: Neurodegenerative Diseases 2012 Report Considers a Different Approach to Drug Discovery in this Disease Area to Date
The Global Neurodegenerative Diseases Market 2015-2019 research report says reformulation of marketed drugs is boosting the growth of neurodegenerative diseases market during the period reviewed for forecasts in this research.
Neurodegenerative Diseases Market to Grow at 4.7% CAGR to 2019
Led by researchers from the Research Institute of the MUHC, the Universite de Montreal and the Hopital du Sacre-CA[pounds sterling]ur de Montreal, the study showed that the chance that a a patient with an REM sleep behaviour disorder would develop a neurodegenerative disease was 17.
Sleep disorder linked to neurodegenerative disease
Precise determinations of neurodegenerative disease can be elusive, although for approximately 80% of cases, a diagnosis made by a clinician is confirmed postmortem (Mok et al.
Neurodegenerative diseases: an overview of environmental risk factors
To determine whether the mutant mRNAs were specific to ALS, Rothstein's group examined brain and spinal cord tissue from 24 people who had died of other neurodegenerative diseases or non-neurological causes.
Clue to Lou Gehrig's disease emerges
Table 30: Neurodegenerative Disease Market, Alzheimer's Disease, Revenue by Country ($m), 2002-2010 38
Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain Growth
Elixir will own the rights to the new compounds for use in all disease areas, excluding neurodegenerative diseases, for which Siena Biotech will have the right to obtain an exclusive license.
Elixir Pharmaceuticals and Siena Biotech S.p.A. Enter Agreement to Evaluate SIRT1 Inhibitors in Huntington's Disease
AD/PD(TM) is now the world's foremost platform devoted to promoting the latest advances in neurodegenerative disease research and new therapies.
AD/PD(TM) 2015 Showcases the Latest Research and New Therapies in Alzheimer's, Parkinson's and Related Brain Diseases

Encyclopedia browser ?
Full browser ?